BioMark to Advance Development of Cancer Treatment for Glioblastoma
BioMark Diagnostics Inc. an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers is pleased to announce today it has received non-dilutive research funding from a...
Source: marketscreener.com